These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38088459)

  • 21. Associations Among Different Domains of Quality Among US Liver Transplant Programs.
    Brown CS; Waits SA; Englesbe MJ; Sonnenday CJ; Sheetz KH
    JAMA Netw Open; 2021 Aug; 4(8):e2118502. PubMed ID: 34369991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative mortality in liver transplantation before and after the implementation of the organ allocation policy Share 35.
    Holm ZD; Kolodzie K; Galli AM; Meyhoff CS; Niemann CU; Adelmann D
    Clin Transplant; 2023 Jan; 37(1):e14854. PubMed ID: 36380529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
    Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model for end-stage liver disease score and MELD exceptions: 15 years later.
    Asrani SK; Kamath PS
    Hepatol Int; 2015 Jul; 9(3):346-54. PubMed ID: 26016462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver transplantation: expectation with MELD score for liver allocation in Brazil.
    Teixeira AC; Souza FF; Mota Gde A; Martinelli Ade L; Sankarankutty AK; Silva Ode C
    Acta Cir Bras; 2006; 21 Suppl 1():12-4. PubMed ID: 17013505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OPTN/SRTR 2022 Annual Data Report: Liver.
    Kwong AJ; Kim WR; Lake JR; Schladt DP; Schnellinger EM; Gauntt K; McDermott M; Weiss S; Handarova DK; Snyder JJ; Israni AK
    Am J Transplant; 2024 Feb; 24(2S1):S176-S265. PubMed ID: 38431359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying Sex-Based Disparities in Liver Allocation.
    Locke JE; Shelton BA; Olthoff KM; Pomfret EA; Forde KA; Sawinski D; Gray M; Ascher NL
    JAMA Surg; 2020 Jul; 155(7):e201129. PubMed ID: 32432699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation after share 35: Impact on pretransplant and posttransplant costs and mortality.
    Nicolas CT; Nyberg SL; Heimbach JK; Watt K; Chen HS; Hathcock MA; Kremers WK
    Liver Transpl; 2017 Jan; 23(1):11-18. PubMed ID: 27658200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35.
    Bowring MG; Zhou S; Chow EKH; Massie AB; Segev DL; Gentry SE
    Transplantation; 2019 Oct; 103(10):2113-2120. PubMed ID: 30801545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved retransplant outcomes: early evidence of the share35 impact.
    Brooks JT; Koizumi N; Neglia E; Gdoura B; Wong TW; Kwon C; Smith TE; Ortiz J
    HPB (Oxford); 2018 Jul; 20(7):649-657. PubMed ID: 29500002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Waiting list mortality for pediatric deceased donor liver transplantation in a Japanese living-donor-dominant program.
    Kasahara M; Katono M; Schlegel A; Kubota T; Nakazato Y; Uchida H; Shimizu S; Yanagi Y; Takeda M; Fukuda A; Sakamoto S
    Pediatr Transplant; 2019 Dec; 23(8):e13578. PubMed ID: 31535772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation in the high MELD era: a fair chance for everyone?
    Bahra M; Neuhaus P
    Langenbecks Arch Surg; 2011 Apr; 396(4):461-5. PubMed ID: 21384189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH; Kim DG; Kang M; Koh HH; Choi MC; Min EK; Lee JG; Kim MS; Joo DJ
    Int J Surg; 2023 Nov; 109(11):3459-3466. PubMed ID: 37565633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved posttransplant mortality after share 35 for liver transplantation.
    Kwong AJ; Goel A; Mannalithara A; Kim WR
    Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
    Sotiropoulos GC; Vernadakis S; Paul A; Hoyer DP; Saner FH; Gallinat A
    Dig Dis Sci; 2016 Nov; 61(11):3346-3353. PubMed ID: 27538409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.